DERIVATE VON AMPHOTERICIN B

Patent europeic · EP3283171 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3283171
Numer da la dumonda
EP16780813
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-04-2016
Publitgà
21-02-2018
Concedì
26-05-2021
La protecziun finescha il pli tard
14-04-2036
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
C07H 17/08 (2006.01)
A61P 31/10 (2006.01)
A61P 31/04 (2006.01)
Prioritad
US 201562147949 P 15.04.2015
Dumonda PCT
PCT/US2016/027703 15.04.2016
Publicaziun PCT
WO2016/168568 20.10.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  2. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  3. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  4. 06-04-2022

    Midada

    Published in Swissreg on 06.04.2022

  5. 14-07-2021

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 14.07.2021

  6. 26-05-2021

    Concedì

    Published in Swissreg on 26.05.2021

Partidas

Possessur

Sfunga Therapeutics, Inc.

1403 Old Farm Road, Champaign, IL 61821, US

Represchentant

HGF GmbH

OBC Suisse AG Aeschengraben 29, 4051 Basel

Inventur

BURKE, Martin D.

Champaign, IL 61821, US

THOTTUMKARA, Arun P.

Menlo Park, CA 94025, US

SWEENEY, Zachary K.

Redwood City, CA 95062, US

MELLEM, Kevin T.

Redwood City, CA 94063, US

KOLTUN, Elena S.

Foster City, CA 94404, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.